Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DCL000229

Drug Information
SynonymsSGX523, SGX-523; CHEMBL1236107; S1112_Selleck; EC-000.2355; SGX-523; DB08584
CompanySGX Pharma./Eli Lilly
IndicationSolid Tumors
[ICD9: 140-199, 210-229   ICD10: C00-C75, C7A, C7B, D10-D36, D3A]
Terminated in Phase I    

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCN1C=C(C=N1)C2=NN3C(=NN=C3SC4=CC5=C(C=C4)N=CC=C5)C=C2    
Therapeutic ClassAntineoplastic Agents
PubChem Compound IDCID 24779724.
PubChem Substance IDSID 49704074.
TargetMet proto-oncogene tyrosine kinaseInhibitor[1]
Ref 1CenterWatch. Drugs in Clinical Trials Database. CenterWatch. 2008. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543